← Eichor
Condition: Hepatocellular Carcinoma Childhood Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatocellular Carcinoma Childhood

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Soli
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT06620302Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Phase 2 · 5 location(s) · Allison O'Neill, MD · NCT04134559Molecular Basis of Pediatric Liver Cancer
Phase N/A · 1 location(s) · University of Pittsburgh · NCT03959800
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.